SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-22-014881
Filing Date
2022-05-19
Accepted
2022-05-19 16:25:29
Documents
16
Period of Report
2022-05-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cdxc-20220519.htm   iXBRL 8-K 47406
2 EX-10.1 chromadexcdxc-jointventure.htm EX-10.1 124941
3 EX-99.1 chromadexcdxc-pressrelease.htm EX-99.1 13764
7 image_0.jpg GRAPHIC 17271
8 image_1.jpg GRAPHIC 31406
  Complete submission text file 0001628280-22-014881.txt   413080

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cdxc-20220519.xsd EX-101.SCH 1893
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cdxc-20220519_lab.xml EX-101.LAB 23892
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cdxc-20220519_pre.xml EX-101.PRE 12517
10 EXTRACTED XBRL INSTANCE DOCUMENT cdxc-20220519_htm.xml XML 10520
Mailing Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024
Business Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024 310-388-6706
ChromaDex Corp. (Filer) CIK: 0001386570 (see all company filings)

IRS No.: 262940963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37752 | Film No.: 22943185
SIC: 2833 Medicinal Chemicals & Botanical Products